(Q33503456)

27 July 2017

3 references

3 April 2019

25 June 2019

23 September 2020

Combination studies with gemcitabine in the treatment of non-small-cell lung cancer (English)

1 reference

non-small-cell lung carcinoma

27 July 2017

main subject

3 references

3 April 2019

25 June 2019

23 September 2020

1 reference

3 April 2019

2 references

25 June 2019

23 September 2020

antineoplastic combined chemotherapy protocols

1 reference

23 September 2020

W P Steward

1

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

British Journal of Cancer

27 July 2017

published in

4 references

27 July 2017

3 April 2019

25 June 2019

23 September 2020

78 Suppl 3

1 reference

27 July 2017

page(s)

15-19

1 reference

Weekly gemcitabine with monthly cisplatin: effective chemotherapy for advanced non-small-cell lung cancer

27 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2062800

Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2062800

Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2062800

Phase I/II study of gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: preliminary results

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2062800

Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2062800

Chemotherapy of advanced non-small-cell lung cancer: a comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2062800

CPT-11 (Irinotecan) in the treatment of colorectal cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2062800

Interaction between cisplatin and gemcitabine in vitro and in vivo.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2062800

The pharmacology and clinical use of methotrexate

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2062800

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2062800

Antimetabolites in Cancer Chemotherapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2062800

Cross-linking of Complementary Strands of DNA in Mammalian Cells by Antitumour Platinum Compounds

21 June 2018

1 reference

12 December 2020

Comparison of the cellular pharmacokinetics and toxicity of 2',2'-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine

1 reference

12 December 2020

Metabolism of 2',2'-difluoro-2'-deoxycytidine and radiation sensitization of human colon carcinoma cells

1 reference

12 December 2020

Gemcitabine: current status of phase I and II trials

1 reference

12 December 2020

Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine

1 reference

12 December 2020

Phase I dose-escalation trial of gemcitabine and cisplatin for advanced non-small-cell lung cancer: usefulness of mathematic modeling to determine maximum-tolerable dose

1 reference

12 December 2020

Improved prospects for long-term survival in adults with acute myelogenous leukemia

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1998.749

1 reference

Dimensions Publication ID

27 July 2017

0 references

1 reference

27 July 2017

1 reference